Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Gefjon Pharma ApS
APS
Active
Reklamebeskyttelse
CVR 44512971
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 2 years old
7 employees
www.gefjonpharma.com
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Gefjon Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2025
Income statement
DKK thousands
Item
2025
Gross profit
470
Staff expenses
-718
EBITDA
-248
Depreciation & amort.
-0
EBIT
-248
Net financials
0
Profit before tax
-248
Tax
-52
Net profit
-196
Balance sheet
DKK thousands
Item
2025
Total assets
5.331
Equity
-156
Long-term debt
4.000
Short-term debt
1.487
Total debt
5.487
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-52.8%
This company
2025
2025
Soliditetsgrad
-2.9%
This company
38.2%
Market median
-108% vs market
2025
2025
Egenkapitalforrentning
-19550400.0%
This company
18.4%
Market median
-106252274% vs market
2025
2025
Nettoresultatgrad (af bruttofortjeneste)
-41.6%
This company
2025
2025
Aktivomsætning (af bruttofortjeneste)
0.09×
This company
2025
2025
Gæld/egenkapital
35.28×
This company
0.62×
Market median
-5590% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2023-12-19 – 2025-03-31
View
PDF
More on Gefjon Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
